Gram Positive Agents Flashcards

1
Q

glycopeptides

A

vancomycin

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

streptogramins

A

quinupristin:dalfopristin

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

oxazolidinones

A

linezolid
tedezolid

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

lipopeptides

A

daptomycin

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

lipoglycopeptides

A

telavancin
oritavancin
dalbovancin

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

vancomycin MOA

A

inhibits 2nd stage of cell wall synthesis by binding to the D-Ala-D-Ala cell wall precursors

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

vancomycin cidal or static, time or conc dependent

A

bactericidal, slow

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

mechanism of resistance vancomycin

A

modification of the D-Ala-D-Ala vancomycin binding site

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

spectrum of activity vancomycin

A

gram positives
anaerobes

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

target organisms vancomycin

A

PRSP
MSSA
MRSA
C. diff (po only)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

which is drug of choice for MRSA

A

vancomycin

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

when should we measure serum

A

1 hour after end of infusion

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

does vanc penetrate CSF

A

no

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

how is vanc eliminated? dose adjust?

A

excreted by kidney, requires dose adjustments based on CrCl

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

which gram positive agent can be used for c. diff?

A

vancomycin orally

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

adverse events of vancomycin

A

red man syndrome
neohrotoxicity, ototoxicity
interstitial phlebitis

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

risk factors for nephro and ototoxicity

A

high doses
prolonged therapy
use of other agents causing nephro or ototox like chemo or pressors

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

how does red man syndrome happen

A

related to rate of infusion, happens if given fast

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

if red man syndrome happens, can you give vancomycin again

A

can give it again but prolong the infusion or give pretreatment with antihistamines or corticosteroids

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
20
Q

mechanism of action quinupristin/dalfopristin

A

inhibits protein synthesis by binding to 50S ribosomal subunits

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
21
Q

quinupristin:dalfopristan cidal or static, conc or time dependent

A

static, time dependent

22
Q

linezolid, tedizolid MOA

A

inhibits protein synthesis by binding to the 50S ribosomal subunit near 30S interface

23
Q

linezolid, tedizolid static or cidal, time or conc

A

static
time dependent (linezolid)
conc dependent (tedizolid)

24
Q

mechanism of action daptomycin

A

causes membrane depolarization by inserting lipophillic tail in cell wall to form transmembrane channel, inhibits DNA synthesis

25
Q

daptomycin, cidal or static, time or conc dependent

A

cidal
concentration dependent

26
Q

telavancin, oritavancin, dalbavancin MOA

A

inhibits cell wall synthesis by binding to D-Ala-D-Ala cell wall precursors AND causes cell membrane depolarization by inserting lipophilic tail in cell wall

27
Q

telavancin, oritavancin, dalbavacin cidal or static, time or con

A

cidal
concentration dependent

28
Q

Synercid mechanism of resistance

A

alteration in ribosomal binding site, enzymatic inactivation

29
Q

linezolid, tedizolid mechanism of resistance

A

alteration in ribosomal binding site (rare)

30
Q

daptomycin mechanism of resistance

A

rarely reported, altered cell wall membrane binding through loss of membrane protein

31
Q

telavancin, oritavancin, dalbovancin mechanism of resistance

A

modification of the D-Ala-D-Ala vancomycin binding site

32
Q

spectrum of activity Synercid (quinupristin, dalfopristin)

A

gram positives only
anaerobes

33
Q

spectrum of activity linezolid, tedizolid

A

gram positive only
anaerobes

34
Q

spectrum of activity daptomycin

A

gram positives only
anaerobes

35
Q

spectrum of activity telavancin, oritavancin, dalbovancin

A

gram positives only
anaerobes

36
Q

target organisms for gram positive agents

A

PRSP
MRSA
MSSA
VRE (except quinupristin: dalfopristin)

37
Q

gram positive agents covering VISA and VRSA

A

linezolid, tidezolid
daptomycin
telavancin, oritavancin, dalbovancin

38
Q

which gram positve agents have CSF penetration?

39
Q

which gram positives require renal dose adjustments

A

daptomycin
telavancin
dalbavancin

40
Q

which gram positive requires hepatic dose adjustments

41
Q

side effects of Synercid (quinupristin, dalfopristin)

A

phlebitis
myalgias
arthralgias

42
Q

linezolid side effects

A

optic and peripheral neuropathy
thrombocytopenia, anemia

43
Q

daptomycin side effects

A

myopathy and CPK elevation
acute eosinophillic pneumonia

44
Q

telavancin, oritavancin, dalbovancin side effects

A

nephrotoxicity
QT prolongation
taste werd
infusion site reactions

45
Q

which drug has risk of serotonin syndrome?

46
Q

which drug has interaction with HmgCoa reductase?

A

daptomycin, hold the statin

47
Q

which drug has CYP3a4 interaction

48
Q

what drugs should you avoid with Synercid

A

3A4s
cyclosporine
statins
tacrolimus
carbamezepine

49
Q

which drug interacts with aPTT tests

A

oritavancin, dalbovancin, telavancin

50
Q

which gram positive should we avoid in pregnancy

A

dalbavancin, oritavancin, telavancin

51
Q

which drugs preferred for VRE

A

linezolid
daptomycin